SAMSCA DIN 02370468
Health Canada record
| Active ingredient(s) | TOLVAPTAN 15 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03XA01 TOLVAPTAN |
| Original market date | 22-Sep-2011 |
| Current status date | 22-Sep-2011 |
| Source | Health Canada DPD |
Establishment licence of the holder
Otsuka Pharmaceutical Co., Ltd. — licence , not currently licensed, last inspection rating C (2025-07-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOLVAPTAN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02491575 | JINARC | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 15 MG; TOLVAPTAN 15 MG | Marketed |
| 02491583 | JINARC | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 30 MG; TOLVAPTAN 15 MG | Marketed |
| 02437503 | JINARC | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 45 MG; TOLVAPTAN 15 MG | Marketed |
| 02437511 | JINARC | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 60 MG; TOLVAPTAN 30 MG | Marketed |
| 02437538 | JINARC | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 90 MG; TOLVAPTAN 30 MG | Marketed |
| 02557215 | LUPIN-TOLVAPTAN | LUPIN PHARMA CANADA LIMITED | Tablet | TOLVAPTAN 90 MG; TOLVAPTAN 30 MG | Marketed |
| 02557193 | LUPIN-TOLVAPTAN | LUPIN PHARMA CANADA LIMITED | Tablet | TOLVAPTAN 45 MG; TOLVAPTAN 15 MG | Marketed |
| 02557207 | LUPIN-TOLVAPTAN | LUPIN PHARMA CANADA LIMITED | Tablet | TOLVAPTAN 60 MG; TOLVAPTAN 30 MG | Marketed |
| 02557177 | LUPIN-TOLVAPTAN | LUPIN PHARMA CANADA LIMITED | Tablet | TOLVAPTAN 15 MG; TOLVAPTAN 15 MG | Marketed |
| 02557185 | LUPIN-TOLVAPTAN | LUPIN PHARMA CANADA LIMITED | Tablet | TOLVAPTAN 30 MG; TOLVAPTAN 15 MG | Marketed |
| 02370484 | SAMSCA | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 60 MG | Approved |
| 02370476 | SAMSCA | OTSUKA PHARMACEUTICAL CO LTD | Tablet | TOLVAPTAN 30 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 12536 | 2011-07-25 | New Drug Submission (NDS) |
International API supply for TOLVAPTAN
19 active FDA Drug Master Files.
Request a quote for SAMSCA